药物和神经递质受体.药物和神经递质受体. 具有临床相关性的新视角
1Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Md 21205.
JAMA
|June 2, 1989
概括
受体结合技术揭示了多种药物和神经递质受体亚型,包括抗体和二胺受体,对各种疾病和药物作用具有重大临床影响.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 受体结合技术显著提高了对药物和神经递质相互作用的理解.
- 多种受体亚型,如抗体和二甲受体,具有临床相关性.
研究的目的:
- 突出多个受体亚型的临床意义,重点关注抗体和二甲受体.
- 为了说明各种药物如何与这些受体亚型相互作用,导致治疗或不良影响.
主要方法:
- 检查受体结合技术及其在药理学中的应用.
- 通过通道和二甲受体介导的药物效应的分析.
主要成果:
- 通道与许多药物的治疗和不良影响有关,包括洛佩拉米德化物,硫胺化物和氨基糖化物.
- 升高的抗体受体可能在高性心肌病症中起作用.
- 二类药物对不同的中央和外周受体起作用,调节神经递质,并影响内分泌腺.
结论:
- 了解各种受体亚型对于预测药物的疗效和毒性至关重要.
- 抗体和类受体是治疗干预和了解疾病病理生理学的关键目标.
相关概念视频
Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...


